UNDERWRITING AGREEMENT between OKYO PHARMA LIMITED and THINKEQUITY LLC as Representative of the Several Underwriters OKYO PHARMA LIMITEDUnderwriting Agreement • December 5th, 2022 • OKYO Pharma LTD • Biological products, (no disgnostic substances) • New York
The undersigned, OKYO Pharma Limited a company with limited liability formed under the laws of Guernsey (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of OKYO Pharma Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with ThinkEquity LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
